BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34392598)

  • 21. Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    Gardinali NR; Guimarães JR; Melgaço JG; Kevorkian YB; Bottino FO; Vieira YR; da Silva AC; Pinto DP; da Fonseca LB; Vilhena LS; Uiechi E; da Silva MC; Moran J; Marchevsky RS; Cruz OG; Otonel RA; Alfieri AA; de Oliveira JM; Gaspar AM; Pinto MA
    PLoS One; 2017; 12(3):e0174070. PubMed ID: 28328941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone-Mediated Enhancement of Hepatitis E Virus Replication in Human Liver Cells.
    Sooryanarain H; Ahmed SA; Meng XJ
    mBio; 2021 Jun; 12(3):e0143421. PubMed ID: 34154410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
    Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
    J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
    Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
    Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
    Ollivier-Hourmand I; Lebedel L; Lecouf A; Allaire M; Nguyen TTN; Lier C; Dao T
    BMC Infect Dis; 2020 Jul; 20(1):522. PubMed ID: 32677900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients.
    Lhomme S; Abravanel F; Dubois M; Sandres-Saune K; Rostaing L; Kamar N; Izopet J
    J Virol; 2012 Sep; 86(18):10006-14. PubMed ID: 22761386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
    Chen S; Wei F; Wu T; Xia N
    Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation.
    van der Eijk AA; Pas SD; de Man RA
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):143-150. PubMed ID: 28624102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
    Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
    Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report.
    Te HS; Drobeniuc J; Kamili S; Dong C; Hart J; Sharapov UM
    Transplant Proc; 2013 Mar; 45(2):810-3. PubMed ID: 23498824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis E: when to treat and how to treat.
    Abbas Z; Afzal R
    Antivir Ther; 2014; 19(2):125-31. PubMed ID: 24192696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys.
    Byrnes-Blake KA; Pederson S; Klucher KM; Anderson-Haley M; Miller DM; Lopez-Talavera JC; Freeman JA
    J Interferon Cytokine Res; 2012 May; 32(5):198-206. PubMed ID: 22280056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis E Virus Infects Neurons and Brains.
    Zhou X; Huang F; Xu L; Lin Z; de Vrij FMS; Ayo-Martin AC; van der Kroeg M; Zhao M; Yin Y; Wang W; Cao W; Wang Y; Kushner SA; Marie Peron J; Alric L; de Man RA; Jacobs BC; van Eijk JJ; Aronica EMA; Sprengers D; Metselaar HJ; de Zeeuw CI; Dalton HR; Kamar N; Peppelenbosch MP; Pan Q
    J Infect Dis; 2017 Apr; 215(8):1197-1206. PubMed ID: 28199701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV.
    Jagjit Singh GK; Ijaz S; Rockwood N; Farnworth SP; Devitt E; Atkins M; Tedder R; Nelson M
    J Infect; 2013 Jan; 66(1):103-6. PubMed ID: 22166370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response.
    Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q
    Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidences of HEV genotype 3 persistence and reactivity in liver parenchyma from experimentally infected cynomolgus monkeys (Macaca fascicularis).
    Mejido DCP; de Oliveira JM; Gaspar AMC; Gardinali NR; Bottino FO; de Carvalho LG; Lopes Dos Santos DR; Kevorkian YB; Xavier LL; Moran J; Pelajo-Machado M; Marchevsky RS; Pinto MA
    PLoS One; 2019; 14(6):e0218472. PubMed ID: 31211801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
    Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H
    Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.